| Literature DB >> 30787405 |
Bie Ekblad1, Per Eugen Kristiansen2.
Abstract
The structure of the individual peptides of the two-peptideEntities:
Year: 2019 PMID: 30787405 PMCID: PMC6382864 DOI: 10.1038/s41598-019-38518-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Sequences of the two peptides Pls-α (A) and Pls-β (B) investigated in this paper. Above the sequences, green bars illustrate sequence fragments that are active and red bars sequence fragments that are inactive according to Soliman et al.[12]. Below the sequences, the solid bars indicate the GxxxG and GxxxG-like motifs. The effect on activity by replacing the A, S or G residues in the black-barred A/S/GxxxA/S/G motifs with A, G or L and the bold W and Y residues with Y, W, L and R have been investigated in this paper.
Figure 2CD spectra of Pls-α in (A) and Pls-β in (B). The spectra in buffer solution, 50%/50% TFE/water, and 10 mM DPC are drawn with dashed, dotted and solid lines, respectively.
Figure 3NMR structures of Pls-α (A,C,E) and Pls-β (B,D,F) in DPC micelles. (A,B) show the respective NMR structure ensembles of the 20 lowest energy structures. (C,D) show the cartoon representation of the structures. The atomic bonds with side chain residues are shown in (E,F). Positively charged, negatively charged, polar and non-polar residues are colored blue, red, green and light gray, respectively. All figures were generated by molmol[57].
Bacterial inhibitory concentration and relative bacterial inhibitory concentration values from activity measurements of GxxxG and GxxxG-like peptide variants of Pls-α and Pls-β together with the wild type complementary peptide.
| Peptide combinationb | Bacterial inhibitory concentration (nM) | Relative bacterial inhibitory concentration valuesa | ||
|---|---|---|---|---|
| α + β | 0.6 ± 0.1 | 0.17 ± 0.04 | 1 | 1 |
| α(G9A) + β | 11.4 ± 0.9 | 3.7 ± 1.0 | 20 | 20 |
| α(G9L) + β | >25 | >25 | >40 | >150 |
| α(G13A) + β | 1.0 ± 0.1 | 0.36 ± 0.05 | 2 | 2 |
| α(G13L) + β | >25 | >25 | >40 | >150 |
| α(A15G) + β | 6.1 ± 1.5 | 1.25 ± 0.75 | 10 | 7 |
| α(A15L) + β | 0.7 ± 0.1 | 0.25 ± 0.04 | 1 | 1 |
| α(G19A) + β | 0.8 ± 0.2 | 0.22 ± 0.04 | 1 | 1 |
| α(G19L) + β | 4.3 ± 0.6 | 0.33 ± 0.02 | 7 | 2 |
| β(S6G) + α | 0.8 ± 0.1 | 0.23 ± 0.06 | 1 | 1 |
| β(S6A) + α | 0.6 ± 0.1 | 0.15 ± 0.05 | 1 | 1 |
| β(S6L) + α | 1.2 ± 0.1 | 0.29 ± 0.08 | 2 | 2 |
| β(A10G) + α | 1.7 ± 0.4 | 0.41 ± 0.12 | 2 | 2 |
| β(A10L) + α | 0.7 ± 0.1 | 0.26 ± 0.06 | 1 | 1 |
| β(A14G) + α | 3.1 ± 0.4 | 0.59 ± 0.09 | 5 | 3 |
| β(A14L) + α | 1.4 ± 0.1 | 0.36 ± 0.06 | 2 | 2 |
| β(S17G) + α | 5.4 ± 0.3 | 1.1 ± 0.35 | 9 | 6 |
| β(S17A) + α | 2.4 ± 0.2 | 0.51 ± 0.19 | 4 | 3 |
| β(S17L) + α | 10 ± 1 | 1.3 ± 0.9 | 17 | 8 |
| β(G21A) + α | 4.1 ± 0.3 | 1.0 ± 0.47 | 7 | 6 |
| β(G21L) + α | >25 | >25 | >40 | >150 |
aThe relative bacterial inhibitory concentration is defined as a fold increase or decrease in activity compared to the wild type combination.
bThe peptides were added in equimolar amounts. α and β are Pls-α and Pls-β, respectively. Single amino acid substitutions are indicated in parentheses.
Bacterial inhibitory concentration and relative bacterial inhibitory concentration values from activity measurements of wild type combinations of Pls-α, Pls-β, Mur-α and Mur-β.
| Peptide combinationb | Bacterial inhibitory concentration (nM) | Relative bacterial inhibitory concentration valuesa | ||
|---|---|---|---|---|
| Pls-α | >1000 | 91 ± 5 | >1500 | 650 |
| Pls-β | >1000 | >1000 | >1500 | >7000 |
| Mur-α | >1000 | >1000 | >1500 | >7000 |
| Mur-β | >1000 | 670 ± 120 | >1500 | 5000 |
| Pls-α + Pls-β | 0.7 ± 0.2 | 0.14 ± 0.02 | 1 | 1 |
| Mur-α + Mur-β | 2.1 ± 0.4 | 0.23 ± 0.06 | 3 | 2 |
| Pls-α + Mur-α | >1000 | 26 ± 5 | >1400 | 200 |
| Pls-α + Mur-β | 2.2 ± 0.3 | 0.63 ± 0.01 | 3 | 5 |
| Pls-β + Mur | 3.2 ± 0.7 | 0.63 ± 0.01 | 5 | 5 |
| Pls-β + Mur-β | >1000 | 270 ± 120 | >1400 | 2000 |
aThe relative bacterial inhibitory concentration is defined as a fold increase or decrease in activity compared to the wild type combination of Pls-α and Pls-β.
Sequence alignment of individual peptides of two-peptide bacteriocins illustrating identical or similar residues.
| Peptide | Amino acid sequencea |
|---|---|
|
| |
| Pls-α |
|
| Mur-α |
|
| Plantaricin Eb[ |
|
|
| |
| Pls-β |
|
| Mur-β |
|
| Lactococcin G-β[ |
|
aHyphens indicate amino acids that are not present in these peptides, bold letters indicate motifs identified to be important for bacteriocin activity and underlined letters indicate conserved or similar residues in plantaricin S that correspond to the important motifs identified in the other peptides. Bold/italic and italic boxes illustrate amino acids that are identical or similar, respectively, to the individual peptides of plantaricin S.
bThere are at least two ways that plantaricin E[40] can be aligned with Pls-α.
cNumbering with regards to the sequence of plantaricin S.
Figure 4Proposed antiparallel model of the bacteriocin plantaricin S inserted into a membrane bilayer. Structures are drawn in cartoon format, Trp and Tyr residues are shown with side chains colored in light gray and green, respectively, while side chains of N-terminal positively charged residues are colored in blue. The proposed interaction motifs are inside the stapled box.